UDP-glucuronosyltransferases (UGTs) in neuro-olfactory tissues: Expression, regulation, and function

Drug Metabolism Reviews

Volumn 42, Issue 1, 2010, Pages 74-97

  Heydel, Jean Marie ^a   Holsztynska, Elzbieta J ^b   Legendre, Ariéle ^a   Thiebaud, Nicolas ^a   Artur, Yves ^a   Le Bon, Anne Marie ^a  

^a CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^b GeaMedica Inc   (United States)

Author keywords

Blood brain barrier; Brain distribution; Olfactory bulb; Olfactory cortex; Olfactory epithelium; Perireceptor events; Xenobiotic metabolizing enzymes

Indexed keywords

GLUCURONOSYLTRANSFERASE; XENOBIOTIC AGENT;

BLOOD BRAIN BARRIER; DETOXIFICATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; IN SITU HYBRIDIZATION; NONHUMAN; OLFACTORY BULB; OLFACTORY CORTEX; OLFACTORY EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SMELLING; TISSUE DISTRIBUTION; XENOBIOTIC METABOLISM;

EID: 74549165687     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602530903208363     Document Type: Review

References (222)

1. ABA: Te Allen Mouse Brain Atlas (ABA 2009; http://www.brain-map.org)
2. Albert, C., Barbier, O., Vallee, M., Beaudry, G., Belanger, A., Hum, D. W. (2000). Distribution of uridine diphosphate-glucu ronosyltransferase (UGT) expression and activity in cynomol-gus monkey tissues: evidence for diferential expression of steroid-conjugating UGT enzymes in steroid target tissues. Endocrinology 141:2472-2480.
3. Anderson, G. D. (2008). Gender diferences in pharmacological response. Int Rev Neurobiol 83:1-10.
4. Barbier, O., Girard, C., Breton, R., Belanger, A., Hum, D. W. (2000). N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes. Biochemistry 39:11540-11552.
5. Barbier, O., Trottier, J., Kaeding, J., Caron, P., Verreault, M. (2009). Lipid-activated transcription factors control bile acid glucuro-nidation. Mol Cell Biochem 326:3-8.
6. Barret, A., Forestier, L., Deslys, J. P., Julien, R., Gallet, P. F. (2005). Glycosylation-related gene expression in prion diseases: PrPSc accumulation in scrapie infected GT1 cells depends on beta-1,4-linked GalNAc-4-SO4 hyposulfation. J Biol Chem 280:10516-10523.
7. Basu, N. K., Kole, L., Basu, M., Chakraborty, K., Mitra, P. S., Owens, I.S. (2008). Te major chemical-detoxifying system of UDP- glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C. J Biol Chem 283:23048-23061.
8. Bayer, S. A. (1983). 3H-thymidine-radiographic studies of neurogen-esis in the rat olfactory bulb. Exp Brain Res 50:329-340.
9. Belyanskaya, L., Weigel, S., Hirsch, C., Tobler, U., Krug, H.F., Wick P. (2009). Efects of carbon nanotubes on primary neurons and glial cells. Neurotoxicology 30:497-521. [Epub 2009 Mar 24].
10. Ben-Arie, N., Khen, M., Lancet, D. (1993). Glutathione S-transferases in rat olfactory epithelium: purifcation, molecular properties, and odorant biotransformation. Biochem J 292(Pt 2):379-384.
11. Berkowicz, D. A., Trombley, P. Q. (2000). Dopaminergic modulation at the olfactory nerve synapse. Brain Res 855:90-99.
12. Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., et al. (2000). Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical signifcance. Pharmacogenetics 10:679-685.
13. Bjorkhem, I., Andersson, U., Ellis, E., Alvelius, G., Ellegard, L., Diczfalusy, U., et al. (2001). From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem 276:37004-37010.
14. Bjorkhem, I., Eggertsen, G. (2001). Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol 12:97-103.
15. Bock, K. W., Kohle, C. (2005). UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Meth Enzymol 400:57-75.
16. Bond, J. A. (1983). Some biotransformation enzymes responsible for polycyclic aromatic hydrocarbon metabolism in rat nasal tur-binates: efects on enzyme activities of in vitro modifers and intraperitoneal and inhalation exposure of rats to inducing agents. Cancer Res 43:4805-4811.
17. Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., Mangelsdorf, D. J. (2006). Anatomical profling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789-799.
18. Bosio, A., Binczek, E., Le Beau M.M., Fernald, A.A., Stofel, W. (1996). Te human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 34:69-75.
19. Bosma, P. J., Goldhoorn, B., Oude Elferink, R. P., Sinaasappel, M., Oostra, B. A., Jansen, P.L. (1993). A mutation in bilirubin uri-dine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology 105:216-220.
20. Bosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R. P., Chowdhury, J. R., et al. (1994). Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuro-nidating isoform in man. J Biol Chem 269:17960-17964.
21. Brittebo, E. B. (1993). Metabolism of xenobiotics in the nasal olfactory mucosa: implications for local toxicity. Pharmacol Toxicol 72(Suppl 3):50-52.
22. Buck, L., Axel, R. (1991). A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65:175-187.
23. Buck, L. B. (2005). Unraveling the sense of smell (Nobel lecture). Angew Chem Int Ed Engl 44:6128-6140.
24. Buckley, D. B., Klaassen, C. D. (2007). Tissue-and gender-specifc mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 35:121-127.
25. Buckley, D. B., Klaassen, C. D. (2009a). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive andros-tane receptor, pregnane × receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847-856.
26. Buckley, D. B., Klaassen, C. D. (2009b). Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney. Drug Metab Dispos 37:834-840.
27. Caillier, B., Lepine, J., Tojcic, J., Menard, V., Perusse, L., Belanger, A., et al. (2007). A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenet Genom 17:481-495.
28. Calderon, F., Kim, H. Y. (2004). Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 90:979-988.
29. Catania, V. A., Dannenberg, A. J., Luquita, M. G., Sanchez Pozzi, E. J., Tucker, J. K., Yang, E. K., et al. (1995). Gender-related difer-ences in the amount and functional state of rat liver UDP-glucuronosyltransferase. Biochem Pharmacol 50:509-514.
30. Charlier, T. D., Balthazart, J. (2005). Modulation of hormonal signaling in the brain by steroid receptor coactivators. Rev Neurosci 16:339-357.
31. Chat, M., Bayol-Denizot, C., Suleman, G., Roux, F., Minn, A. (1998). Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells. Life Sci 62:151-163.
32. Chen, J., Tu, Y., Moon, C., Nagata, E., Ronnett, G. V. (2003). Heme oxy-genase-1 and heme oxygenase-2 have distinct roles in the proliferation and survival of olfactory receptor neurons mediated by cGMP and bilirubin, respectively. J Neurochem 85:1247-1261.
33. Chen, S., Beaton, D., Nguyen, N., Senekeo-Efenberger, K., Brace-Sinnokrak, E., Argikar, U., et al. (2005). Tissue-specifc, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547-37557.
34. Chowdhury, J. R., Kondapalli, R., Chowdhury, N. R. (1993). Gunn rat: a model for inherited defciency of bilirubin glucuronidation. Adv Vet Sci Comp Med 37:149-173.
35. Christrup, L. L. (1997). Morphine metabolites. Acta Anaesthesiol Scand 41:116-122.
36. Ciotti, M., Marrone, A., Potter, C., Owens, I. S. (1997). Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7:485-495.
37. Cofman, B. L., Rios, G. R., King, C. D., Tephly, T. R. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
38. Court, M. H. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104-116.
39. Court, M. H., Hazarika, S., Krishnaswamy, S., Finel, M., Williams, J. A. (2008). Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 74:744-754.
40. Dahlin, A., Royall, J., Hohmann, J. G., Wang, J. (2009). Expression profling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ter 329:558-570.
41. Daidoji, T., Gozu, K., Iwano, H., Inoue, H., Yokota, H. (2005). UDP-glucuronosyltransferase isoforms catalyzing glucuronidation of hydroxy-polychlorinated biphenyls in rat. Drug Metab Dispos 33:1466-1476.
42. Danielyan, L., Schafer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., et al. (2009). Intranasal delivery of cells to the brain. Eur J Cell Biol 88:315-324.
43. Das, U. N. (2006). Essential Fatty acids-a review. Curr Pharm Biotechnol 7:467-482.
44. Davies, D. C., Brooks, J. W. and Lewis, D. A. (1993). Axonal loss from the olfactory tracks in Alzhelmer's disease. Neurobiol Aging. 14:353-357.
45. Davila, N. G., Blakemore, L. J., Trombley, P. Q. (2003). Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J Neurophysiol 90:395-404.
46. De Leon, J. (2003). Glucuronidation enzymes, genes, and psychiatry. Int J Neuropsychopharmacol 6:57-72.
47. de Zwart, L., Scholten, M., Monbaliu, J. G., Annaert, P. P., Van Houdt, J. M., Van den Wyngaert, I., et al. (2008). Te ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 26:220-230.
48. Dehay, C., Kennedy, H. (2009). Transcriptional regulation and alternative splicing make for better brains. Neuron 62:455-457.
49. Dietschy, J. M. (2009). Central nervous system: cholesterol turnover, brain development, and neurodegeneration. Biol Chem 390:287-293.
50. Dietschy, J. M., Turley, S. D. (2004). Tematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375-1397.
51. Ding, X., Dahl, A. R. (2003) Olfactory mucosa: composition, enzymatic localization, and metabolism. In: Doty, R. L. (Ed.), Handbook of olfaction and gustation, 2nd ed. (pp 51-73). New York: Marcel Dekker, Inc.
52. Ding, X. X., Porter, T. D., Peng, H. M., Coon, M. J. (1991). cDNA and derived amino acid sequence of rabbit nasal cytochrome P450NMb (P450IIG1), a unique isozyme possibly involved in olfaction. Arch Biochem Biophys 285:120-125.
53. Dore, S., Takahashi, M., Ferris, C. D., Zakhary, R., Hester, L. D., Guastella, D., et al. (1999). Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96:2445-2450.
54. Doty, R. L., Reyes, P. F. and Gregar, T. (1987). Presence of both odor identifcation and detection defcits in Alzheimer's disease. Brain Res Bull. 18:597-600.
55. Doty, R. L. (2008). Te olfactory vector hypothesis of neurodegenera-tive disease: is it viable? Ann Neurol 63:7-15
56. du Bois, T. M., Deng, C., Huang, X. F. (2005). Membrane phospholi-pid composition, alterations in neurotransmitter systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:878-888.
57. Duguay, Y., Baar, C., Skorpen, F., Guillemette, C. (2004). A novel functional polymorphism in the uridine diphosphate-glucuronosyl-transferase 2B7 promoter with signifcant impact on promoter activity. Clin Pharmacol Ter 75:223-233.
58. Dutheil, F., Beaune, P., Loriot, M. A. (2008). Xenobiotic metabolizing enzymes in the central nervous system: contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie 90:426-436.
59. Ehmer, U., Vogel, A., Schutte, J. K., Krone, B., Manns, M. P., Strassburg, C. P. (2004). Variation of hepatic glucuroni-dation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39:970-977.
60. Ferreyra-Moyano, H., Barragan, E. (1989). Te olfactory system and Alzheimer's disease. Int J Neurosci 49:157-197.
61. Finel, M., Kurkela, M. (2008). Te UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70-76.
62. Fong, K. J., Kern, R. C., Foster, J. D., Zhao, J. C., Pitovski, D. Z. (1999). Olfactory secretion and sodium, potassium-adenosine tri-phosphatase: regulation by corticosteroids. Laryngoscope 109:383-388.
63. Frances, B., Gout, R., Monsarrat, B., Cros, J., Zajac, J. M. (1992). Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. J Pharmacol Exp Ter 262:25-31.
64. Fricchione, G., Zhu, W., Cadet, P., Mantione, K. J., Bromfeld, E., Madsen, J., et al. (2008). Identifcation of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Monit 14:CS45-CS49.
65. Gage, F. H. (2002). Neurogenesis in the adult brain. J Neurosci 22:612-613.
66. Gardner-Stephen, D. A., Mackenzie, P. I. (2008). Liver-enriched transcription factors and their role in regulating UDP-glucuronosyltransferase gene expression. Curr Drug Metab 9:439-452.
67. Gerozissis, K. (2008). Brain insulin, energy, and glucose homeos-tasis; genes, environment, and metabolic pathologies. Eur J Pharmacol 585:38-49.
68. Getchell, T. V., Margolis, F. L., Getchell, M. L. (1984). Perireceptor and receptor events in vertebrate olfaction. Prog Neurobiol 23:317-345.
69. Ghersi-Egea, J. F., Leininger-Muller, B., Minn, A., Siest, G. (1992). Drug metabolizing enzymes in the rat pituitary gland. Prog Brain Res 91:373-378.
70. Ghersi-Egea, J. F., Leninger-Muller, B., Suleman, G., Siest, G., Minn, A. (1994). Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62:1089-1096.
71. Ghersi-Egea, J. F., Minn, A., Siest, G. (1988). A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels. Life Sci 42:2515-2523.
72. Ghersi-Egea, J. F., Perrin, R., Leininger-Muller, B., Grassiot, M. C., Jeandel, C., Floquet, J., et al. (1993). Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 45:647-658.
73. Ghersi-Egea, J. F., Walther, B., Decolin, D., Minn, A., Siest, G. (1987). Te activity of 1-naphthol-UDP-glucuronosyltransferase in the brain. Neuropharmacology 26:367-372.
74. Gofot, F., Chartoire, N., Vasseur, L., Heikkinen, S., Dembele, D., Le Merrer, J., et al. (2007). Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell 131:405-418.
75. Goswami, S. K., Das, D. K. (2009). Resveratrol and chemoprevention. Cancer Lett 284:1-6. [Epub 2009 Mar 3].
76. Gradinaru, D., Minn, A. L., Artur, Y., Minn, A., Heydel, J. M. (2009). Drug metabolizing enzyme expression in rat choroid plexus: efects of in vivo xenobiotics treatment. Arch Toxicol 83:581-586.
77. Gradinaru, D., Suleman, F. G., Leclerc, S., Heydel, J. M., Grillasca, J. P., Magdalou, J., Minn, A. (1999). UDP-glucuronosyltransferase in the rat olfactory bulb: identifcation of the UGT1A6 isoform and age-related changes in 1-naphthol glucuronidation. Neurochem Res 24:995-1000.
78. Graf, C. L., Pollack, G. M. (2004). Drug transport at the blood-brain barrier and the choroid plexus. Curr Drug Metab 5:95-108.
79. Grunewald, S., Matthijs, G. (2000). Congenital disorders of glycosyla-tion (CDG): a rapidly expanding group of neurometabolic disorders. Neuropediatrics 31:57-59.
80. Guevara, J., Espinosa, B., Zenteno, E., Vazguez, L., Luna, J., Perry, G., et al. (1998). Altered glycosylation pattern of proteins in Alzheimer's disease. J Neuropathol Exp Neurol 57:905-914.
81. Haberly, L. B. (2001). Parallel-distributed processing in olfactory cortex: new insights from morphological and physiological analysis of neuronal circuitry. Chem Senses 26:551-576.
82. Hagglund, M., Berghard, A., Strotmann, J., Bohm, S. (2006). Retinoic acid receptor-dependent survival of olfactory sensory neurons in postnatal and adult mice. J Neurosci 26:3281-3291.
83. Haining, R. L., Nichols-Haining, M. (2007). Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action? Pharmacol Ter 113:537-545.
84. Hanson, L. R., Frey, W. H., 2nd. (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9(Suppl 3):S5.
85. Henry, L. A., Witt, D. M. (2002). Resveratrol: phytoestrogen efects on reproductive physiology and behavior in female rats. Horm Behav 41:220-228.
86. Heurtaux, T., Benani, A., Bianchi, A., Moindrot, A., Gradinaru, D., Magdalou, J., et al. (2004). Redox state alteration modulates astrocyte glucuronidation. Free Radic Biol Med 37:1051-1063.
87. Heurtaux, T., Benani, A., Moulin, D., Muller, N., Netter, P., Minn, A. (2006). Induction of UGT1A6 isoform by infammatory conditions in rat astrocytes. Neuropharmacology 50:317-328.
88. Heydel, J., Leclerc, S., Bernard, P., Pelczar, H., Gradinaru, D., Magdalou, J., et al. (2001). Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis. Brain Res Mol Brain Res 90:83-92.
89. Hilger, P. A. (1989). Applied anatomy and physiology of the nose. In: Adams, G. L., Boies, L., Hilger, P. A. (Eds.), Fundamentals of otolaryngology. A textbook of ear, nose and throat diseases (pp. 177-195). Philadelphia, Pennsylvania, USA: W.B.Saunders.
90. Hook, G. E., Haseman, J. K., Lucier, G. W. (1975). Induction and suppression of hepatic and extrahepatic microsomal foreign-compound-metabolizing enzyme systems by 2,3,7,8-tetrachlorod-ibenzo-p-dioxin. Chem Biol Interact 10:199-214.
91. Huang, Y. H., Galijatovic, A., Nguyen, N., Geske, D., Beaton, D., Green, J., et al. (2002). Identifcation and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2, and UGT1A8*3. Pharmacogenetics 12:287-297.
92. Iida, A., Saito, S., Sekine, A., Mishima, C., Kitamura, Y., Kondo, K., et al. (2002). Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15, and UGT8. J Hum Genet 47:505-510.
93. Illum, L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1-18.
94. Illum, L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 56:3-17.
95. Ingebrigtsen, K., Hektoen, H., Andersson, T., Klasson Wehler, E., Bergman, A., Brandt, I. (1992). Enrichment of metabolites in the cerebrospinal fuid of cod (Gadus morhua) following oral administration of hexachlorobenzene and 2,4',5-trichlorobiphe-nyl. Pharmacol Toxicol 71:420-425.
96. Iolascon, A., Perrotta, S., Coppola, B., Carbone, R., Miraglia Del Giudice E. (2000). Frequency of Gilbert's syndrome associated with UGTA1 (TA)(7) polymorphism in Southern Italy. Haematologica 85:335-336.
97. Ishii, H., Tsurugizawa, T., Ogiue-Ikeda, M., Asashima, M., Mukai, H., Murakami, G., et al. (2007). Local production of sex hormones and their modulation of hippocampal synaptic plasticity. Neuroscientist 13:323-334.
98. Itaaho, K., Mackenzie, P. I., Ikushiro, S., Miners, J. O., Finel, M. (2008). Te confguration of the 17-hydroxy group variably infuences the glucuronidation of beta-estradiol and epiestradiol by human UDP- glucuronosyltransferases. Drug Metab Dispos 36:2307-2315.
99. Iwai, M., Maruo, Y., Ito, M., Yamamoto, K., Sato, H., Takeuchi, Y. (2004). Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 49:123-128.
100. Jacobson, J. L., Jacobson, S. W. (1997). Evidence for PCBs as neu-rodevelopmental toxicants in humans. Neurotoxicology 18:415-424.
101. Jacobson, J. L., Jacobson, S. W., Humphrey, H. E. (1990). Efects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 116:38-45.
102. Jedlitschky, G., Cassidy, A. J., Sales, M., Pratt, N., Burchell, B. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340(Pt 3):837-843.
103. Kapitonov, D., Yu, R. K. (1997). Cloning, characterization, and expression of human ceramide galactosyltransferase cDNA. Biochem Biophys Res Commun 232:449-453.
104. Kapitulnik, J. (2004). Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 66:773-779.
105. Keller, A., Zhuang, H., Chi, Q., Vosshall, L. B., Matsunami, H. (2007). Genetic variation in a human odorant receptor alters odour perception. Nature 449:468-472.
106. King, C. D., Rios, G. R., Assouline, J. A., Tephly, T. R. (1999). Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identifcation of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys 365:156-162.
107. King, S. R. (2008). Emerging roles for neurosteroids in sexual behavior and function. J Androl 29:524-533.
108. Kurosaki, M., Terao, M., Barzago, M. M., Bastone, A., Bernardinello, D., Salmona, M., et al. (2004). Te aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase homologue 3, a novel member of the molybdo-favoenzyme family with selective expression in the olfactory mucosa. J Biol Chem 279:50482-50498.
109. Lambert, J. G., Resink, J. W. (1991). Steroid glucuronides as male pheromones in the reproduction of the African catfsh, Clarias gariepinus-a brief review. J Steroid Biochem Mol Biol 40:549-556.
110. Lampe, J. W., Bigler, J., Bush, A. C., Potter, J. D. (2000). Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 9:329-333.
111. Lazard, D., Tal, N., Rubinstein, M., Khen, M., Lancet, D., Zupko, K. (1990). Identifcation and biochemical analysis of novel olfacto-ry-specifc cytochrome P-450IIA and UDP-glucuronosyl trans-ferase. Biochemistry 29:7433-7440.
112. Lazard, D., Zupko, K., Poria, Y., Nef, P., Lazarovits, J., Horn, S., et al. (1991). Odorant signal termination by olfactory UDP-glucuronosyl transferase. Nature 349:790-793.
113. Leclerc, S., Heydel, J. M., Amosse, V., Gradinaru, D., Cattarelli, M., Artur, Y., et al. (2002). Glucuronidation of odorant molecules in the rat olfactory system: activity, expression, and age-linked modifcations of UDP-glucuronosyltransferase isoforms, UGT1A6 and UGT2A1, and relation to mitral cell activity. Brain Res Mol Brain Res 107:201-213.
114. Lee, C. H., Mo, J. H., Shim, S. H., Ahn, J. M., Kim, J. W. (2008). Efect of ginkgo biloba and dexamethasone in the treatment of 3-methylindole-induced anosmia mouse model. Am J Rhinol 22:292-296.
115. Lein, E. S. Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., et al. (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168-176.
116. Leininger, B., Ghersi-Egea, J. F., Siest, G., Minn, A. (1991). In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-beta-D-glucuronide. J Neurochem 56:1163-1168.
117. Leininger-Muller, B., Ghersi-Egea, J. F., Siest, G., Minn, A. (1994). Induction and immunological characterization of the uridine diphosphate- glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci Lett 175:37-40.
118. Levesque, E., Beaulieu, M., Green, M. D., Tephly, T. R., Belanger, A., Hum, D. W. (1997). Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325.
119. Lim, Y. P., Huang, J. D. (2008). Interplay of pregnane × receptor with other nuclear receptors on gene regulation. Drug Metab Pharmacokinet 23:14-21.
120. Little, J. M., Kurkela, M., Sonka, J., Jantti, S., Ketola, R., Bratton, S., et al. (2004). Glucuronidation of oxidized fatty acids and pros-taglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. J Lipid Res 45:1694-1703.
121. Little, J. M., Williams, L., Xu, J., Radominska-Pandya, A. (2002). Glucuronidation of the dietary fatty acids, phytanic acid, and docosahexaenoic acid, by human UDP-glucuronosyltransferases. Drug Metab Dispos 30:531-533.
122. Liu, Z., Kim, J., Sypek, J. P., Wang, I. M., Horton, H., Oppenheim, F. G., et al. (2004). Gene expression profles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 114:783-790.
123. Longo, V., Citti, L., Gervasi, P. G. (1988). Biotransformation enzymes in nasal mucosa and liver of Sprague-Dawley rats. Toxicol Lett 44:289-297.
124. Lu, Y., Bratton, S., Heydel, J. M., Radominska-Pandya, A. (2008). Efect of retinoids on UDP-glucuronosyltransferase 2B7 mRNA expression in Caco-2 cells. Drug Metab Pharmacokinet 23:364-372.
125. Lu, Y., Heydel, J. M., Li, X., Bratton, S., Lindblom, T., Radominska-Pandya, A. (2005). Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative far-nesoid × receptor response element. Drug Metab Dispos 33:937-946.
126. Lutjohann, D. (2006). Cholesterol metabolism in the brain: importance of 24S-hydroxylation. Acta Neurol Scand Suppl 185:33-42.
127. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677-685.
128. Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., Lewinsky, R. H., Jorgensen, B. R., Nishiyama, T., et al. (2003). Regulation of UDP-glucuronosyltransferase genes. Curr Drug Metab 4:249-257.
129. Mackenzie, P. L., Rogers, A., Treloar, J., Jorgensen, B.R., Miners, J. O. and Meech, R. (2008). Identifcation of UDP glycosyl transferase 3A1 as a UDP N-acetylglucosaminyl transferase. J Biol Chem. 283: 36205-36210.
130. Maden, M. (2007). Retinoic acid in the development, regeneration, and maintenance of the nervous system. Nat Rev Neurosci 8:755-765.
131. Mahboob, M., Kaleem, M., Siddiqui, J. (2004). Efects of a novel organophosphorus pesticide (RPR-V) on extra hepatic detoxifying enzymes after repeated oral doses in rats. Toxicology 202:159-164.
132. Mahboob, M., Siddiqui, M. K. (2002). Long-term efects of a novel phosphorothionate (RPR-II) on detoxifying enzymes in brain, lung, and kidney rats. Ecotoxicol Environ Saf 53:355-360.
133. Maibeche-Coisne, M., Merlin, C., Francois, M. C., Porcheron, P., Jacquin-Joly, E. (2005). P450 and P450 reductase cDNAs from the moth, Mamestra brassicae: cloning and expression patterns in male antennae. Gene 346:195-203.
134. Maibeche-Coisne, M., Nikonov, A. A., Ishida, Y., Jacquin-Joly, E., Leal, W. S. (2004). Pheromone anosmia in a scarab beetle induced by in vivo inhibition of a pheromone-degrading enzyme. Proc Natl Acad Sci U S A 101:11459-11464.
135. Mano, N., Goto, T., Uchida, M., Nishimura, K., Ando, M., Kobayashi, N., et al. (2004a). Presence of protein-bound uncon-jugated bile acids in the cytoplasmic fraction of rat brain. J Lipid Res 45:295-300.
136. Mano, N., Sato, Y., Nagata, M., Goto, T., Goto, J. (2004b). Bioconversion of 3-beta-hydroxy-5-cholenoic acid into chenodeoxycholic acid by rat brain enzyme systems. J Lipid Res 45:1741-1748.
137. Martinasevic, M. K., King, C. D., Rios, G. R. and Tephly, T. R. (1998). Immunochistochemical localization of UDP-glucuronosyl transferases in rat brain during early development. Drug Metab Dispos. 26:1039-1041.
138. Mayer, U., Ungerer, N., Klimmeck, D., Warnken, U., Schnolzer, M., Frings, S., et al. (2008). Proteomic analysis of a membrane preparation from rat olfactory sensory cilia. Chem Senses 33:145-162.
139. Meech, R., Mackenzie, P. I. (1997). Structure and function of urid-ine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907-915.
140. Mendez-Otero, R., Zaverucha-do-Valle, C., Gubert, F., Freitas, G. R., Santiago, M. F. (2005). Regulation and function of neurogenesis in the adult vertebrate brain. Braz J Med Biol Res 38:1553-1559.
141. Merkus, F. W., van den Berg, M. P. (2007). Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory. Drugs R D 8:133-144.
142. Merlin, C., Francois, M. C., Bozzolan, F., Pelletier, J., Jacquin-Joly, E., Maibeche-Coisne, M. (2005). A new aldehyde oxidase selectively expressed in chemosensory organs of insects. Biochem Biophys Res Commun 332:4-10.
143. Minn, A., Ghersi-Egea, J. F., Perrin, R., Leininger, B., Siest, G. (1991). Drug metabolizing enzymes in the brain and cerebral microves-sels. Brain Res Brain Res Rev 16:65-82.
144. Minn, A., Leclerc, S., Heydel, J. M., Minn, A. L., Denizcot, C., Cattarelli, M., et al. (2002). Drug transport into the mammalian brain: the nasal pathway and its specifc metabolic barrier. J Drug Targ 10:285-296.
145. Minn, A. L., Pelczar, H., Denizot, C., Martinet, M., Heydel, J. M., Walther, B., et al. (2005). Characterization of microsomal cyto-chrome P450-dependent monooxygenases in the rat olfactory mucosa. Drug Metab Dispos 33:1229-1237.
146. Misiti, S., Koibuchi, N., Bei, M., Farsetti, A., Chin, W. W. (1999). Expression of steroid receptor coactivator-1 mRNA in the developing mouse embryo: a possible role in olfactory epithelium development. Endocrinology 140:1957-1960.
147. Miyawaki, A., Homma, H., Tamura, H., Matsui, M., Mikoshiba, K. (1996). Zonal distribution of sulfotransferase for phenol in olfactory sustentacular cells. Embo J 15:2050-2055.
148. Mofatt, C. A. (2003). Steroid hormone modulation of olfactory processing in the context of sociosexual behaviors in rodents and humans. Brain Res Brain Res Rev 43:192-206.
149. Monte, J. C., Nagle, M. A., Eraly, S. A., Nigam, S. K. (2004). Identifcation of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 323:429-436.
150. Mori, K., Nagao, H.,Yoshihara, Y. (1999). Te olfactory bulb: coding and processing of odor molecule information. Science 286:711-715.
151. Muller, A., Glattard, E., Taleb, O., Kemmel, V., Laux, A., Miehe, M., et al. (2008). Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS ONE 3:e1641.
152. Nagano, E., Yamada, H., Oguri, K. (2000). Characteristic glucuroni-dation pattern of physiologic concentration of morphine in rat brain. Life Sci 67:2453-2464.
153. Nef, P., Heldman, J., Lazard, D., Margalit, T., Jaye, M., Hanukoglu, I., et al. (1989). Olfactory-specifc cytochrome P-450. cDNA cloning of a novel neuroepithelial enzyme possibly involved in chemoreception. J Biol Chem 264:6780-6785.
154. Neri, C., Ghelardini, C., Sotak, B., Palmiter, R. D., Guarna, M., Stefano, G., et al. (2008). Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo. J Neurochem 106:2337-2344.
155. Neri, C., Guarna, M., Bianchi, E., Sonetti, D., Matteucci, G., Stefano, G. B. (2004). Endogenous morphine and codeine in the brain of non human primate. Med Sci Monit 10:MS1-MS5.
156. Nguyen, N., Bonzo, J. A., Chen, S., Chouinard, S., Kelner, M. J., Hardiman, G., et al. (2008). Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease. J Biol Chem 283:7901-7911.
157. Norlin, M., Wikvall, K. (2007). Enzymes in the conversion of cholesterol into bile acids. Curr Mol Med 7:199-218.
158. Ohno, S., Kawana, K., Nakajin, S. (2008). Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glu-curonidation and its kinetic properties. Drug Metab Dispos 36:688-694.
159. Operana, T. N., Tukey, R. H. (2007). Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo-and heterodimeri-zation analysis by fuorescence resonance energy transfer and coimmunoprecipitation. J Biol Chem 282:4821-4829.
160. Osborne, R., Joel, S., Trew, D., Slevin, M. (1990). Morphine and metabolite behavior after diferent routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ter 47:12-19.
161. Pause, B. M. (2004). Are androgen steroids acting as pheromones in humans? Physiol Behav 83:21-29.
162. Persidsky, Y., Ramirez, S. H., Haorah, J., Kanmogne, G. D. (2006). Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1:223-236.
163. Petzold, G. C., Hagiwara, A., Murthy, V. N. (2009). Serotonergic modulation of odor input to the mammalian olfactory bulb. Nat Neurosci [Epub 2009 Aug 11].
164. Pignatelli, A., Kobayashi, K., Okano, H., Belluzzi, O. (2005). Functional properties of dopaminergic neurones in the mouse olfactory bulb. J Physiol 564:501-514. (Pubitemid 40585049)
165. Pompeiano, M., Palacios, J. M., Mengod, G. (1994). Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23:163-178.
166. Radominska-Pandya, A., Bratton, S., Little, J. M. (2005). A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Curr Drug Metab 6:141-160.
167. Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E., Mackenzie, P. I. (1999). Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
168. Rogers, M. E., Jani, M. K., Vogt, R. G. (1999). An olfactory-specifc glutathione-S-transferase in the sphinx moth, Manduca sexta. J Exp Biol 202:1625-1637.
169. Rosen, G. D., La Porte, N. T., Diechtiaref, B., Pung, C. J., Nissanov, J., Gustafson, C., Bertrand, L., Gefen, S., Fan, Y., Tretiak, O. J., Manly, K. F., Park, M. R., Williams, A. G., Connolly, M. T., Capra, J. A. and Williams, R.
170. Rosenfeld, M. G., Lunyak, V. V., Glass, C. K. (2006). Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428.
171. Roy-Chowdhury, J., Locker, J., Roy-Chowdhury, N. (2003). Nuclear receptors orchestrate detoxifcation pathways. Dev Cell 4:607-608.
172. Rybczynski, R., Reagan, J., Lerner, M. R. (1989). A pheromone-de-grading aldehyde oxidase in the antennae of the moth, Manduca sexta. J Neurosci 9:1341-1353.
173. Sabolovic, N., Heurtaux, T., Humbert, A. C., Krisa, S., Magdalou, J. (2007). cis-and trans-resveratrol are glucuronidated in rat brain, olfactory mucosa, and cultured astrocytes. Pharmacology 80:185-192.
174. Saeki, M., Ozawa, S., Saito, Y., Jinno, H., Hamaguchi, T., Nokihara, H., et al. (2002). Tree novel single nucleotide polymorphisms in UGT1A10. Drug Metab Pharmacokinet 17:488-490.
175. Saeki, M., Saito, Y., Jinno, H., Sai, K., Komamura, K., Ueno, K., et al. (2003). Tree novel single nucleotide polymorphisms in UGT1A9. Drug Metab Pharmacokinet 18:146-149.
176. Samokyszyn, V. M., Gall, W. E., Zawada, G., Freyaldenhoven, M. A., Chen, G., Mackenzie, P. I., et al. (2000). 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem 275:6908-6914.
177. Santa Maria, C., Machado, A. (1988). Changes in some hepatic enzyme activities related to phase II drug metabolism in male and female rats as a function of age. Mech Ageing Dev 44:115-125.
178. Schef, S. W., Price, D. A., Schmitt, F. A. and Mufson, E. J. (2006). Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 27:1372-1384.
179. Shelby, M. K., Cherrington, N. J., Vansell, N. R., Klaassen, C. D. (2003). Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 31:326-333.
180. Shepherd, G. M. (2004). Te human sense of smell: are we better than we think? PLoS Biol 2:E146.
181. Shepherd, G. M. (2007). Perspectives on olfactory processing, conscious perception, and orbitofrontal cortex. Ann N Y Acad Sci 1121:87-101.
182. Stakhiv, T. M., Mesia-Vela, S., Kaufman, F. C. (2006). Phase II anti-oxidant enzyme activities in brain of male and female ACI rats treated chronically with estradiol. Brain Res 1104:80-91.
183. Sten, T., Bichlmaier, I., Kuuranne, T., Leinonen, A., Yli-Kauhaluoma, J., Finel, M. (2009). UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specifcity in testosterone and epit-estosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos 37:417-423.
184. Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., et al. (2002a). Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259-265.
185. Strassburg, C. P., Vogel, A., Kneip, S., Tukey, R. H., Manns, M. P. (2002b). Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50:851-856.
186. Sugatani, J., Sueyoshi, T., Negishi, M., Miwa, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane × receptor, and glucocor-ticoid receptor. Meth Enzymol 400:92-104. (Pubitemid 43052417)
187. Suleman, F. G., Abid, A., Gradinaru, D., Daval, J. L., Magdalou, J., Minn, A. (1998). Identifcation of the uridine diphosphate glu- curonosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch Biochem Biophys 358:63-67.
188. Suleman, F. G., Ghersi-Egea, J. F., Leininger-Muller, B., Minn, A. (1993). Uridine diphosphate-glucuronosyltransferase activities in rat brain microsomes. Neurosci Lett 161:219-222.
189. Sullivan, J. M., Benton, J. L., Beltz, B. S. (2000). Serotonin depletion in vivo inhibits the branching of olfactory projection neurons in the lobster deutocerebrum. J Neurosci 20:7716-7721.
190. Sunkin, S. M., Hohmann, J. G. (2007). Insights from spatially mapped gene expression in the mouse brain. Hum Mol Genet 16(Spec No. 2):R209-R219.
191. Takeda, S., Ishii, Y., Iwanaga, M., Nurrochmad, A., Ito, Y., Mackenzie, P. I., et al. (2009). Interaction of cytochrome P450 3A4 and UDP-glucuronosyltransferase 2B7: evidence for protein-protein association and possible involvement of CYP3A4 J-helix in the interaction. Mol Pharmacol 75:956-964.
192. Tamura, H. O., Harada, Y., Miyawaki, A., Mikoshiba, K., Matsui, M. (1998). Molecular cloning and expression of a cDNA encoding an olfactory-specifc mouse phenol sulphotransferase. Biochem J 331(Pt 3):953-958.
193. Tassoni, D., Kaur, G., Weisinger, R. S., Sinclair, A. J. (2008). Te role of eicosanoids in the brain. Asia Pac J Clin Nutr 17(Suppl 1):220-228.
194. Terasaki, T., Pardridge, W. M. (2000). Targeted drug delivery to the brain; (blood-brain barrier, efux, endothelium, biological transport). J Drug Target 8:353-355.
195. Tierry-Mieg, D., Tierry-Mieg, J. (2006). AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7(Suppl 1):S12. 11-14. [Epub 2006 Aug 7].
196. Tum, T., Erpenbeck, V. J., Moeller, J., Hohlfeld, J. M., Krug, N., Borlak, J. (2006). Expression of xenobiotic metabolizing enzymes in diferent lung compartments of smokers and nonsmokers. Environ Health Perspect 114:1655-1661.
197. Tin Tin Win, S., Mitsushima, D., Yamamoto, S., Fukushima, A., Funabashi, T., Kobayashi, T., et al. (2008). Changes in neuro-transmitter levels and proinfammatory cytokine mRNA expressions in the mice olfactory bulb following nanoparticle exposure. Toxicol Appl Pharmacol 226:192-198.
198. Tukey, R. H., Strassburg, C. P. (2000). Human UDP- glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616.
199. Turgeon, D., Chouinard, S., Belanger, P., Picard, S., Labbe, J. F., Borgeat, P., et al. (2003). Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 44:1182-1191.
200. Turman, C. M., Hatley, J. M., Ryder, D. J., Ravindranath, V., Strobel, H. W. (2006). Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues. Exp Opin Drug Metab Toxicol 2:399-418.
201. Upadhyay, U. D., Holbrook, E. H. (2004). Olfactory loss as a result of toxic exposure. Otolaryngol Clin North Am 37:1185-1207.
202. Verreault, M., Senekeo-Efenberger, K., Trottier, J., Bonzo, J. A., Belanger, J., Kaeding, J., et al. (2006). Te liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44:368-378.
203. Vessey, D. A., Zakim, D. (1974). Membrane fuidity and the regulation of membrane-bound enzymes. Horiz Biochem Biophys 1:138-174.
204. Viani, A., Temellini, A., Tusini, G., Pacifci, G. M. (1990). Human brain sulphotransferase and glucuronyltransferase. Hum Exp Toxicol 9:65-69.
205. Villeneuve, L., Girard, H., Fortier, L. C., Gagne, J. F., Guillemette, C. (2003). Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and favopiridol anticancer drugs. J Pharmacol Exp Ter 307:117-128.
206. Vogel, A., Kneip, S., Barut, A., Ehmer, U., Tukey, R. H., Manns, M. P., et al. (2001). Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121:1136-1144.
207. Wahlstrom, A., Hammar, L., Lundin, L. G., Rane, A. (1986). Morphine metabolism in mouse brain. NIDA Res Monogr 75:603-606.
208. Wahlstrom, A., Lundin, L. G., Ask, B., Rane, A. (1989). Te sensitivity to noxious heat in relation to brain and liver opioid glucuroni-dation in inbred strains of mice. Pain 38:71-75.
209. Wahlstrom, A., Winblad, B., Bixo, M., Rane, A. (1988). Human brain metabolism of morphine and naloxone. Pain 35:121-127.
210. Wang, Q., Hasan, G., Pikielny, C. W. (1999). Preferential expression of biotransformation enzymes in the olfactory organs of Drosophila melanogaster, the antennae. J Biol Chem 274:10309-10315.
211. Wang, R. Y. (1988). Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems. Ann N Y Acad Sci 537:362-379.
212. Wang, T. W., Zhang, H., Parent, J. M. (2005). Retinoic acid regulates postnatal neurogenesis in the murine subventricular zone-olfactory bulb pathway. Development 132:2721-2732.
213. Whitby-Logan, G. K., Weech, M., Walters, E. (2004). Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa. Brain Res 995:151-157.
214. Winner, B., Cooper-Kuhn, C. M., Aigner, R., Winkler, J., Kuhn, H. G. (2002). Long-term survival and cell death of newly generated neurons in the adult rat olfactory bulb. Eur J Neurosci 16:1681-1689.
215. Winner, B., Geyer, M., Couillard-Despres, S., Aigner, R., Bogdahn, U., Aigner, L., et al. (2006). Striatal deaferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 197:113-121.
216. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: a knowledgebase for the human metabo-lome. Nucleic Acids Res 37:D603-D610.
217. Wojtasek, H., Leal, W. S. (1999). Degradation of an alkaloid phe-romone from the pale-brown chafer, Phyllopertha diversa (Coleoptera: Scarabaeidae), by an insect olfactory cytochrome P450. FEBS Lett 458:333-336.
218. Yamada, H., Ishii, K., Ishii, Y., Ieiri, I., Nishio, S., Morioka, T., et al. (2003). Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain. J Toxicol Sci 28:395-401.
219. Yamamoto, S., Oka, S., Saito-Ohara, F., Inazawa, J., Kawasaki, T. (2002). Molecular cloning and genomic analysis of mouse glucuronyltransferase involved in biosynthesis of the HNK-1 epitope. J Biochem 131:337-347.
220. Zakim, K., Vessey, D. A. (1975). Regulation of microsomal enzymes by phospholipids. IX. Production of uniquely modifed forms of microsomal UDP-glucuronyltransferase by treatment with phospholipase A and detergents. Biochim Biophys Acta 410:61-73.
221. Zhang, X., Zhang, Q. Y., Liu, D., Su, T., Weng, Y., Ling, G., et al. (2005). Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa. Drug Metab Dispos 33:1423-1428.
222. Zhuo, X., Gu, J., Behr, M. J., Swiatek, P. J., Cui, H., Zhang, Q. Y., et al. (2004). Targeted disruption of the olfactory mucosa-specifc Cyp2g1 gene: impact on acetaminophen toxicity in the lateral nasal gland, and tissue-selective efects on Cyp2a5 expression. J Pharmacol Exp Ter 308:719-728